pyridostigmine bromide has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; He, X; Liu, LZ; Yang, Y; Yu, XJ; Zang, WJ; Zhao, M | 1 |
Ismail, I; Lewis, M; Peters, JR; Scanlon, MF | 1 |
Giustina, A; Ndon, JA; Wehrenberg, WB | 1 |
3 other study(ies) available for pyridostigmine bromide and Alloxan Diabetes
Article | Year |
---|---|
Pyridostigmine regulates glucose metabolism and mitochondrial homeostasis to reduce myocardial vulnerability to injury in diabetic mice.
Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucose; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Ischemia; Myocytes, Cardiac; Oxidative Stress; Pyridostigmine Bromide | 2019 |
Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release.
Topics: Acetylcholine; Analysis of Variance; Animals; Antibodies, Monoclonal; Depression, Chemical; Diabetes Mellitus, Experimental; Glucose; Growth Hormone; Growth Hormone-Releasing Hormone; Injections, Intravenous; Insulin; Insulin Secretion; Male; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Rats, Wistar; Somatostatin | 1995 |
Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats.
Topics: Animals; Antibodies; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Growth Hormone; Growth Hormone-Releasing Hormone; Hypothalamus; Male; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Somatostatin | 1992 |